Patch reported that a Northville business was promoting EXOMIND, a magnetic-pulse brain stimulation device described as FDA-cleared for depression.
EXOMIND promotion reported in Northville
Patch (Across Michigan) reported that a Northville business was offering EXOMIND, which the source described as a novel, noninvasive brain stimulation treatment intended to enhance mental wellness. Patch’s report said the device was being promoted for people dealing with depression or anxiety.
According to Patch, an internal medicine physician specializing in aesthetics described EXOMIND as an FDA-cleared treatment for depression. The report did not provide independent information about regulatory documentation, clinical evidence, or how the treatment compares with other depression treatments.
How the device was described
Patch reported that EXOMIND uses an applicator that delivers magnetic pulses to stimulate or suppress brain activity. According to the source, the technology targets brain areas involved in emotional regulation, cognitive function, and self-control.
The report said sessions are conducted on a walk-in, walk-out basis. Patch also stated that doctors recommend treatment twice a week for three weeks to maximize results.
Patch reported claims that EXOMIND users often describe improved sleep, energy, and emotional resilience. The source also said research shows reduced food cravings and that many users report weight loss after treatment. These were claims included in the source report.
Event details in the report
Patch reported that the Northville business planned a Wellness Party on Oct. 23, from 4 to 7 p.m., where attendees could try a demonstration of the EXOMIND treatment. According to Patch, the event listing also included refreshments, raffle prizes, and special pricing.
The Patch article appeared during National Depression and Mental Health Screening Month, according to its headline and event description. The source primarily presented the device as a wellness and depression-related offering rather than reporting on a broader change in Michigan health coverage, state policy, or public mental health services.
Local treatment information
Patch’s report focused on one Northville-based offering and described the device’s promotional claims, treatment format, and planned demonstration event. It did not discuss insurance coverage, referral requirements, pricing, clinician training standards, or availability through other Michigan providers.
What this means for Michigan patients
For people looking for treatment locally, the directory lists 55 published clinics in Michigan; Patch’s report may help identify questions to ask about a device, its intended use, and treatment setting.
This is general information, not medical advice.
More Michigan reporting on treatment updates.
This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.